Drug Manufacturers -- How Will Expiring Drug Patents Affect Companies in the Healthcare Sector
26 August 2010 - 10:00PM
Marketwired
The Bedford Report examines the outlook for companies in the
Biotechnology Industry and has released analyst reports on Gilead
Sciences (NASDAQ: GILD), Biogen Idec Inc. (NASDAQ: BIIB), Acorda
Therapeutics, Inc. (NASDAQ: ACOR) and Onyx Pharmaceuticals Inc.
(NASDAQ: ONXX). Access to the full company reports can be found at
www.bedfordreport.com.
In recent quarters, expiring patents in the product lines of the
major pharmaceutical companies has become a hot topic. Over the
next five years drug companies are expected to lose several
patents. In order to compensate for expiring drug patents drug
companies have been focusing on mergers and acquisitions in order
to shore up their patent lines.
Like you, we realize that timing is everything. We release daily
market updates so you can stay ahead of the crowd and make the best
investment decisions to maximize your returns. Take a few minutes
to register with us for free at www.bedfordreport.com and get
exclusive access to our numerous analyst reports and industry
newsletters.
Biotech firms in particular have been a beneficiary of this
drive to sign agreements with smaller companies. In addition to
acquisitions, small biotech companies are expected to benefit from
in-licensing activities and collaborations. In recent news Johnson
& Johnson acquired Cougar Biotechnology and Mentor Corp.
Investors can get copies of the full analyst reports on
Gilead Sciences, Biogen Idec, Acorda
Therapeutics and Onyx Pharmaceuticals by
registering for free at www.bedfordreport.com.
The Bedford Report has not been compensated by any of the above
mentioned companies. We act as an independent research portal and
are aware that all investment entails inherent risks. Please view
the full disclaimer at:
http://www.bedfordreport.com/disclaimer.php
Contact: The Bedford Report Email Contact
Onyx Pharmaceuticals, Inc. (MM) (NASDAQ:ONXX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Onyx Pharmaceuticals, Inc. (MM) (NASDAQ:ONXX)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Onyx Pharmaceuticals, Inc. (MM) (NASDAQ): 0 recent articles
More The Bedford Report News Articles